🔗 Permalink

Inventor profile of:

Gary Stephens

City:

Reading

Country:

United Kingdom

Published Applications:

Last publication date:

2022-12-15

Top Assignees for applications by Gary Stephens

The entities that hold a legal rights for patent applications filed by inventor Stephens Gary:

OTSUKA PHARMACEUTICAL CO., LIMITED 8 Tokyo, Japan
GW Pharma Limited 5 Salisbury, United Kingdom
GW Pharma Limited 3 Cambridge, United Kingdom
GW Research Limited 2 Cambridge, United Kingdom
GW Pharma Limited 1 Salisbury, Wiltshire, United Kingdom
GW Pharma Limited 1 Histon, United Kingdom
GW Research Limited 1 Histon, United Kingdom
GW Pharma Limited 1 Wiltshire, United Kingdom
Jazz Pharmaceuticals Research UK Limited 1 Sittingbourne, United Kingdom

Recent patent applications by Stephens Gary

Gary Stephens from Reading, GB has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2022-12-15

US20220395470A1

Human necessities

USE OF THE PHYTOCANNABINOID CANNABIDIOL (CBD) IN COMBINATION WITH A STANDARD ANTI-EPILEPTIC DRUG (SAED) IN THE TREATMENT OF EPILEPSY

#2 | 2022-03-03

US20220062197A1

Human necessities

7-OH-cannabidiol (7-OH-CBD) and/or 7-OH-cannabidivarin (7-OH-CBDV) for use in the treatment of epilepsy

#3 | 2021-04-08

US20210100755A1

Human necessities

Use of the phytocannabinoid cannabidivarin (CBDV) in the treatment of epilepsy

#4 | 2020-07-02

US20200206152A1

Human necessities

7-OH-cannabidiol (7-OH-CBD) and/or 7-OH-cannabidivarin (7-OH-CBDV) for use in the treatment of epilepsy

#5 | 2017-09-28

US20170273913A1

Human necessities

USE OF ONE OR A COMBINATION OF PHYTO-CANNABINOIDS IN THE TREATMENT OF EPILEPSY

#6 | 2015-11-26

US20150335590A1

Human necessities

Use of one or a combination of phyto-cannabinoids in the treatment of epilepsy

#7 | 2015-11-12

US20150320698A1

Human necessities

Use of the phytocannabinoid cannabidivarin (CBDV) in the treatment of epilepsy

#8 | 2014-08-28

US20140243405A1

Human necessities

Pharmaceutical composition comprising the phytocannabinoids cannabidivarin (CBDV) and cannabidiol (CBD)

#9 | 2014-06-05

US20140155456A9

Human necessities

USE OF THE PHYTOCANNABINOID CANNABIDIOL (CBD) IN COMBINATION WITH A STANDARD ANTI-EPILEPTIC DRUG (SAED) IN THE TREATMENT OF EPILEPSY

#10 | 2013-11-07

US20130296398A1

Human necessities

USE OF THE PHYTOCANNABINOID CANNABIDIOL (CBD) IN COMBINATION WITH A STANDARD ANTI-EPILEPTIC DRUG (SAED) IN THE TREATMENT OF EPILEPSY

#11 | 2012-06-28

US20120165402A1

Human necessities

Use of one or a combination of phyto-cannabinoids in the treatment of epilepsy

#12 | 2012-01-05

US20120004251A1

Human necessities

Use of the phytocannabinoid cannabidivarin (CBDV) in the treatment of epilepsy

InventorID:

520150 ⎘